Jt Stratford LLC Eli Lilly & CO Transaction History

Jt Stratford LLC

$568 Million
Q3 2024

A detailed history of Jt Stratford LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jt Stratford LLC holds 3,860 shares of LLY stock, worth $3.05 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

3,860

Previous 4,192 7.92%

Holding current value

$3.05 Million

Previous $3.8 Million 9.91%

% of portfolio

0.6%

Previous 0.73%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $256,350 - $318,726	-332 Reduced 7.92%	3,860 $3.42 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $63,063 - $79,086	87 Added 2.12%	4,192 $3.8 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $240,433 - $321,665	-406 Reduced 9.0%	4,105 $3.19 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $362,906 - $427,818	-691 Reduced 13.28%	4,511 $2.63 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $208,221 - $287,064	-479 Reduced 8.43%	5,202 $2.79 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $386,164 - $516,346	1,101 Added 24.04%	5,681 $2.66 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $40,071 - $47,061	-129 Reduced 2.74%	4,580 $1.57 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.51 Million - $1.76 Million	4,709 New	4,709 $1.72 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $209,190 - $257,438	-944 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $43,332 - $56,049	-240 Reduced 20.27%	944 $217,000
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $194,554 - $251,860	1,184 New	1,184 $221,000
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $227,956 - $263,673	-1,559 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $212,678 - $255,956	1,559 New	1,559 $256,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.

Account